Unknown

Dataset Information

0

Biosafety of non-surface modified carbon nanocapsules as a potential alternative to carbon nanotubes for drug delivery purposes.


ABSTRACT: BACKGROUND: Carbon nanotubes (CNTs) have found wide success in circuitry, photovoltaics, and other applications. In contrast, several hurdles exist in using CNTs towards applications in drug delivery. Raw, non-modified CNTs are widely known for their toxicity. As such, many have attempted to reduce CNT toxicity for intravenous drug delivery purposes by post-process surface modification. Alternatively, a novel sphere-like carbon nanocapsule (CNC) developed by the arc-discharge method holds similar electric and thermal conductivities, as well as high strength. This study investigated the systemic toxicity and biocompatibility of different non-surface modified carbon nanomaterials in mice, including multi-walled carbon nanotubes (MWCNTs), single-walled carbon nanotubes (SWCNTs), carbon nanocapsules (CNCs), and C ?? fullerene (C ??). The retention of the nanomaterials and systemic effects after intravenous injections were studied. METHODOLOGY AND PRINCIPAL FINDINGS: MWCNTs, SWCNTs, CNCs, and C ?? were injected intravenously into FVB mice and then sacrificed for tissue section examination. Inflammatory cytokine levels were evaluated with ELISA. Mice receiving injection of MWCNTs or SWCNTs at 50 µg/g b.w. died while C ?? injected group survived at a 50% rate. Surprisingly, mortality rate of mice injected with CNCs was only at 10%. Tissue sections revealed that most carbon nanomaterials retained in the lung. Furthermore, serum and lung-tissue cytokine levels did not reveal any inflammatory response compared to those in mice receiving normal saline injection. CONCLUSION: Carbon nanocapsules are more biocompatible than other carbon nanomaterials and are more suitable for intravenous drug delivery. These results indicate potential biomedical use of non-surface modified carbon allotrope. Additionally, functionalization of the carbon nanocapsules could further enhance dispersion and biocompatibility for intravenous injection.

SUBMITTER: Tang AC 

PROVIDER: S-EPMC3310837 | biostudies-literature | 2012

REPOSITORIES: biostudies-literature

altmetric image

Publications

Biosafety of non-surface modified carbon nanocapsules as a potential alternative to carbon nanotubes for drug delivery purposes.

Tang Alan C L AC   Hwang Gan-Lin GL   Tsai Shih-Jung SJ   Chang Min-Yao MY   Tang Zack C W ZC   Tsai Meng-Da MD   Luo Chwan-Yao CY   Hoffman Allan S AS   Hsieh Patrick C H PC  

PloS one 20120322 3


<h4>Background</h4>Carbon nanotubes (CNTs) have found wide success in circuitry, photovoltaics, and other applications. In contrast, several hurdles exist in using CNTs towards applications in drug delivery. Raw, non-modified CNTs are widely known for their toxicity. As such, many have attempted to reduce CNT toxicity for intravenous drug delivery purposes by post-process surface modification. Alternatively, a novel sphere-like carbon nanocapsule (CNC) developed by the arc-discharge method holds  ...[more]

Similar Datasets

| S-EPMC9703093 | biostudies-literature
| S-EPMC2562710 | biostudies-literature
| S-EPMC6604718 | biostudies-literature
| S-EPMC8563809 | biostudies-literature
| S-EPMC6062158 | biostudies-literature
| S-EPMC8066293 | biostudies-literature
| S-EPMC4373402 | biostudies-literature
| S-EPMC4475451 | biostudies-literature
| S-EPMC3417041 | biostudies-literature
| S-EPMC2888730 | biostudies-literature